HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

daunorubicinol

main metabolite of daunomycin
Also Known As:
13-dihydrodaunorubicin; daunomycinol; daunorubicinol hydrochloride; dihydrodaunomycin; duborimycin; leukaemomycin D; 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranosyl)oxy)-8-(1-hydroxyethyl)-1-methoxy-6,8,11-trihydroxy-5,12-Naphthacenedione
Networked: 38 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Maser, Edmund: 4 articles (05/2019 - 09/2007)
2. Blanco, Javier G: 4 articles (10/2016 - 07/2014)
3. Mordente, Alvaro: 3 articles (11/2015 - 11/2006)
4. Hintzpeter, Jan: 2 articles (05/2019 - 06/2015)
5. Martin, Hans-Jörg: 2 articles (05/2019 - 06/2015)
6. Cheng, Qiuying: 2 articles (10/2016 - 07/2015)
7. Ferguson, Daniel C: 2 articles (10/2016 - 07/2015)
8. Quiñones-Lombraña, Adolfo: 2 articles (10/2016 - 07/2014)
9. Meucci, Elisabetta: 2 articles (11/2015 - 11/2006)
10. Silvestrini, Andrea: 2 articles (11/2015 - 11/2006)

Related Diseases

1. Cardiotoxicity
2. Neoplasms (Cancer)
3. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
4. Melanoma (Melanoma, Malignant)
5. Sarcoma (Soft Tissue Sarcoma)

Related Drugs and Biologics

1. Daunorubicin (Cerubidine)
2. Enzymes
3. Doxorubicin (Adriamycin)
4. Carbonyl Reductase (NADPH)
5. zorubicin
6. Anthracyclines
7. adriamycinol
8. Oxidoreductases (Dehydrogenase)
9. NADP (NADPH)
10. Antineoplastic Agents (Antineoplastics)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Induction Chemotherapy
4. Aftercare (After-Treatment)